In a study published in the American Journal of Physiology-Endocrinology and Metabolism , Van der Heyden et al
#GLP1Medications #WeightLossJourney #HealthEducation #HealthyLiving To view or add a comment, sign in The DOT recently proposed a rule to add fentanyl and norfentanyl to its mandatory drug testing panel, along with several technical amendments aimed at strengthening safety standards
However, unlike our expectations, a synergistic effect of SGLT2 inhibitor and DPP-4 inhibitor use was not observed in these clinical trials, which could be attributed, at least partially, to the opposite action on glucagon secretion by the two classes of drugs
We dont just provide treatmentswe create personalized wellness protocols built around your body and goals
The findings open the door to a possible dual-purpose role for these drugs in treating both systemic inflammation and cardiovascular comorbidity in RA